Oxford textbook of oncology /
Saved in:
Imprint: | Oxford ; New York : Oxford University Press, 1995. |
---|---|
Description: | 2 v. (xxiii, 2481, 124 p.) : ill. ; 29 cm. |
Language: | English |
Series: | Oxford medical publications. |
Subject: | |
Format: | Print Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/2384912 |
Table of Contents:
- Section I. The Biology of Cancer
- 1.1. The Growth of Human Tumors
- 1.2. Polypeptide and Neuropeptide Growth Factors: Signalling Pathways and Role in Cancer
- 1.3. Differentiation and Cancer
- 1.4. Chromosomes and Cancer
- 1.5. Genetics and Familial Cancer
- 1.6. Oncogents
- 1.7. The Cell Mediated Response to Tumors
- 1.8. Cytokines
- 1.9. Cancer Metastasis
- 1.10. Monoclonal Antibodies
- Section 2. Etiology, Epidemiology and Prevention of Cancer
- 2.1. Cell and Molecular Mechanisms in Chemical Carcinogenesis
- 2.2. Viral Carcionogenesis
- 2.3. Cellular and Molecular Mechanisms in Radiation Carcinogenesis
- 2.4. The Cancer Registry: Organization and Function
- 2.5. Etiological Leads
- 2.8. Prospects for TUmor Chemoprevention
- 2.9. Practical Applications of the New Cancer Genetics
- 2.10. Evaluation of Screening for Cancer
- 2.11. Cancer Epidemiology and Prevention
- Section 3. Diagnosis and Investigative Procedures
- 3.1. Histopathological Classification and Typing of Solid Tumors
- 3.2. New Techniques in Pathology and Their Application in Diagnosis and Studies of Tumor Biology
- 3.3. Cytology
- 3.4. Flow Cytometry
- 3.5. Clinical Approaches to Precancerous States
- 3.6. The Role of Radiological Imaging in the Management of Cancer
- 3.7. Positron Emission Tomography
- 3.8. Magnetic Resonance in Oncology
- 3.9. Interventional Radiology: Percutaneous Tissue Sampling Guided by Imaging
- 3.10. Ultrasonic Scanning
- 3.11. Circulating Tumor Markers
- 3.12. Nuclear Medicine Procedures
- Section 4. The Scientific Basis of Cancer Treatment
- 4.1. Chemotherapy: General Aspects
- 4.2. Biomolecular Structure and Rational Drug Design
- 4.3. Protein Modelling
- 4.4. Structure-activity Relationships of Anticancer Agents
- 4.5. New Drug Development
- 4.6. Alkylating Agents and Related Drugs
- 4.7. Antitumor Antibiotics
- 4.8. Antimetabolitess
- 4.9. Cisplatin and Analogues: Discovery, Mechanism of Action and Clinical Pharmacology
- 4.10. Podophyllotoxins
- 4.11. Vinca Alkaloids: Cellular Pharmacology and Clinical Pharmakinetics
- 4.12. New and Miscellaneous Anticancer Drugs: Future Development of Drug Design
- 4.13. Drug Resistance
- 4.14. High-dose Chemotherapy and Autologous Bone-marrow Rescue
- 4.15. Clinical Uses of Hemopoietic Growth Factors
- 4.16. The Basis of Hormonal Therapy of Cancer
- 4.17. Targeted Therapy with Microspheress and Other Carrier Systems
- 4.18. Monoclonal Antibody Targeting
- 4.19. The Biological Basis of Radiotherapy
- 4.20. Current Practice of Radiotherapy: Physical Basis
- 4.21. External Beam Radiation Therapy Including Conformational Therapy
- 4.22. Interstitial Radiation Therapy
- 4.23. Intracavitary Therapy
- 4.24. Total Body Irradiation
- 4.25. Intraoperative Radiotherapy - An Investigatinoal Approach to Cancer Treatment
- 4.26. Particle Radiotherapy
- 4.27. Targeted Radiotherapy
- 4.28. Hypoxia - Selective Bioreductive Drugs
- 4.29. Clinical Fractionation Studies
- 4.30. Combined Chemotherapy and Radiotherapy
- 4.31. Hyperthermia
- 4.32. Photodynamic Therapy
- 4.33. Lasers in Oncology
- 4.34. Principles of Pharmacokinetics, Principles of Pharmacokinetics
- Section 5. Progress in Cancer Treatment
- 5.1. Surgery Radiotherapy and Chemotherapy
- t(i). Achievement and Obstacles to Progress in Cancer Surgery
- t(ii). Radiotherapy
- t(iii). Achievement of Chemotherapy and Obstacles to Further Progress
- 5.2. Staging Classifications
- Section 6. Skin Cancer and Tumors of the Head and Neck
- 6.1. Skin Cancer Other than Melanoma
- 6.2. Cutaneous Melanoma
- 6.3. The Eye and Orbit
- (i). Melanoma of the Eye and Orbit
- (ii). Tumors of the Orbit
- 6.4. Salivary Tumors
- 6.5. Carcinoma of the Nasal Cavity and Paranasal Sinuses
- 6.7. Tumors of the Oral Cavity
- (i). Epidemiology and Clinicopathological Aspects of Premalignant Lesions. I. Van der Waal
- (ii). The Roles of Surgery in the Treatment of Tumors of the Oral Cavity
- (iii). The Role of Radiotherapy in the Treatment of Tumors of the Oral Cavity. A. Gerbaulet
- 6.8. Tumors of the Oropharynx
- 6.9. Tumors of the Hypopharynx
- 6.10. Tumors of the Larynx
- 6.11. Uncommon Tumors of the Head and Neck Region
- 6.12. Carcinoma of the External Auditory Meatus and Middle Ear
- 6.13. Management of Cervical Lymph Nodes
- 6.14. Chemotherapy in Conjunction with Radiotherapy and/or Surgery in Head and Neck Cancer
- Section 7. Gastrointestinal Tumors
- 7.1. Malignancies of the Oesophagus
- 7.2. Cancer of the Stomach
- 7.3. Malignancies of the Small Bowel
- 7.4. Colorectal Tumors
- 7.5. Radical Radiotherapy of Cancer of the Rectum and Anus
- 7.6. Tumors of the Panceras
- 7.7. Liver Tumors
- 7.8. Tumors of the Biliary Tract
- Section 8. Breast Cancer U. Veronesi
- Section 9. Gynecological Malignancy
- 9.1. Carcinoma of the Ovary
- 9.2. Ovarian Germ-Cell and Other Rare Ovarian Tumors
- 9.3. Carcinoma of the Cervix
- 9.4. Gestational Trophoblastic Tumors
- 9.5. Carcionma of the Vagina
- 9.6. Carcinoma of the Vulva and its Putative Precursors
- 9.7. Sarcoma and Melanoma of the Female Genital System
- 9.8. Tumors of the Endometrium and Adnexa
- Section 10. Urological Cancer
- 10.1. Testicular Tumors
- 10.2. Extragonadal Germ-Cell Tumors
- 10.3. Tumors of the Penis
- 10.4. Bladder Cancer
- 10.5. Tumors of the Kidney (Other than Nephroblastoma)
- 10.6. Tumors of the Prostate
- Section 11. Thoracic Tumors
- 11.1. Tumors of the Trachea and Lung
- 11.2. Mesothelioma
- 11.3. Thymic Tumors with Myasthemia Gravis or Bone Marrow Dyscrasias
- 11.4. Other Thymic Tumors
- 11.5. Surgical Resection of Pulmonary Metastases
- 11.6. Uncommon Thoracic Tumors
- Section 12. Lymphoid and Myeloid Neoplasia
- 12.1. The Biology of Haemopoiesis
- 12.2. Biology of Leukemia
- 12.3. Acute Leukemia
- (i). Acute Leukemia in Adults
- (ii). Acute Leukemia in Childhood
- 12.4. The Chronic Leukemias
- 12.5. Bone Marrow Transplantation for Leukemia
- 12.6. Autologous Bone-marrow Transplantation and Intensification Therapies for Solid Tumors and Lymphomas
- 12.7. Hodgkin's Disease
- (i). The Cell Biology of Hodgkin's Disease. V. Diehl, et al.
- (ii). Hodgkin's Disease in Adults
- (iii). Hodgkin's Disease in Childhood
- 12.8. The Non-Hodgkin's Lymphoma
- (i). The Pathology and Biology of Non-Hodgkin's Lymphoma
- (ii). Non-Hodgkin's Lymphoma in Adults
- (iii). The Non-Hodgkin's Lymphomas in Children
- 12.9. Myeloma and Other Plasma Cell Malignancies
- 12.10. Histiocyte Disorders
- 12.11. Neoplastic Complications of AIIDS
- Section 13. Bone Tumors and Soft Tissue Sarcomas
- 13.1. Sarcoma of the Soft Tissue
- 13.2. Malignant Mesenchymal Tumors in Childhood
- 13.3. Ewing's Sarcoma
- 13.4. Osteosarcoma
- 13.5. Bone Malignant Tumors Other than Osteosarcoma and Ewing's Tumor
- 14. Childhood Tumors
- 14.1. The Molecular Pathology of Childhood Tumors
- 14.2. Neuroblastoma
- 14.3. Retinoblastoma
- 14.4. Wilms' Tumor
- 14.5. Germ Cell Tumors of Childhood
- 14.6. Liver Tumors
- 14.7. Rare Tumors of Childhood
- Section 15. Tumors of the Central Nervous System
- 15.1. Brain Tumors in Children
- 15.2. Tumors of the Brain and Spinal Cord in Adults
- Section 16. Endocrine Tumors
- 16.1. Carcinomas of the Thyroid
- 16.2. Medullary Carcinoma of the Thyroid
- 16.3. Pituitary Tumors
- 16.4. Adrenal Tumors
- 16.5. Neuroendocrine Gastroenteropancreatic Tumors
- Section 17. Tumors of Unknown Primary Site
- Section 18. Cancer in the Elderly D. Raghavan
- Section 19. Medical and Surgical Complications of Cancer
- 19.1. Acute Emergencies in Oncology: General Overview
- 19.2. Metabolic Disturbances
- 19.3. Paraneoplastic Syndromes
- 19.4. Immunological and Hematological Complications of Cancer
- 19.5. Serous Effusions
- 19.6. Spinal Metastatic Disease
- 19.7. Pathological Fracture
- 19.8. Complications Related to Radiotherapy
- 19.9. Complications of Cytotoxic Therapy
- 19.10. Effects of Cancer Chemotherapy on Fertility
- 19.11. Tertogenic Effects of Cancer Treatment
- 19.12. Carcinogenic Effects of Cancer Treatment
- 19.13. Supportive Care, Antemetics, Alimentation
- 19.14. Nutritional Support of Cancer Patients
- Section 20. End-points Quality of Life
- 20.1. Clinical Trial Methodology
- 20.2. Data Management
- 20.3. Quality of Life
- 20.4. Psychological Sequelae of Cancer and its Treatment
- 20.5. Pain Control and Palliation
- 20.6. Rehabilitation of the Cancer Patient
- 20.7. Care of the Dying Patient
- 20.8. The Organization of Cancer Servies
- 20.9. Economic Considerations in Cancer Care
- 20.10. Cancer and Society: Health Education
- 20.11. Support Systems for Cancer Patients